US Patent 10952998 Amlodipine formulations
Patent 10952998 was granted and assigned to Silvergate Pharmaceuticals, Inc. on March, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
July 13, 2020
0
Date of Patent
March 23, 2021
0
Patent Applicant
Patent Application Number
16927678
0
Patent Inventor Names
Gerold L. Mosher
0
Scott Brauer
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10952998 Amlodipine formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
